Form 4 for AMPH Amphastar Pharmaceuticals, Inc.
Accepted 2023-03-20 00:00:00 ET · period of report 2023-03-16 · accession 0001104659-23-034574 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-03-20 | 2023-03-16+ | AMPH | PETERS WILLIAM J | CFO, EVP, Treas | F - Tax | $37.00 | -9,157 | 109.3K | -8% | -$338.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-17 | F | D | 4,162 | $36.29 | 105,148 | D | — | — | (F1) The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units, or RSUs. |
| 2 | Common | Common Stock | 2023-03-16 | F | D | 4,995 | $37.60 | 109,310 | D | — | — | (F1) The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units, or RSUs. |